Op-t-mune, Inc.

Denver, CO 80206

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.53MM
First Award Date 09/01/12
Most Recent Award Date 08/01/17

Key Personnel

Last Name Name Awards Contact
Nelson Peter Nelson 1
WAGNER DAVID H WAGNER 4

5 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 08/01/17 - 07/31/18

Abstract: A major shortfall in clinical care for diabetes is a rapid and accurate screen for progression to disease. Current criteria involve HLA haplotype, and the presence of auto-antibodies (AA). Genome-wide associated studies (GWAS) revealed only immune associated genes including HLA as T1D predictors. The ability to differentiate from other...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 08/01/17 - 07/31/18

Multiple Sclerosis is an inflammatory neurodegenerative disease with autoimmune components that exacerbate and potentially initiate the disease. Diagnosis is invasive, time-consuming, relatively expensive and extremely difficult. In fact no clear diagnostic test yet exist. A major concern is that MS symptoms are identical to the symptoms of nume...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 02/15/17 - 02/14/18

Abstract: Type 1 Diabetes (T1D) affects an ever growing population. While this disease typically has been associated with juveniles, the disease in adult populations is rapidly increasing. The defining clinical component is insulin loss, which occurs because of sustained inflammation in the islets. At present there is no means to prevent or reve...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 06/15/14 - 05/31/15

DESCRIPTION (provided by applicant): The National Multiple Sclerosis (MS) Society reports that 1.2 million people worldwide and more than 400,000 people in the U.S. have clinically diagnosed MS. Currently there are 10 FDA approved drugs for MS but none of the current drugs have impacted the course of MS to prevent relapses or progression of dise...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-DK-11-024
Budget: 09/01/12 - 08/31/13

DESCRIPTION (provided by applicant): The goal of this application is to develop a test kit to quickly and accurately diagnose type 1diabetes;differentiate it from type 2 diabetes and screen for "pre-diabetes". Current screening methods involve multiple blood tests, HLA haplotype and the presence of diabetes associated auto-antibodies. We have d...